Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.9 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |